(Q42511321)

1 November 2017

Different effects of antipsychotic drugs on insulin release in vitro (English)

1 reference

1 November 2017

1 reference

Melkersson K

1

1 reference

1 November 2017

Khan A

series ordinal

2

1 reference

1 November 2017

Hilding A

series ordinal

3

1 reference

1 November 2017

Hulting AL

series ordinal

4

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

European Neuropsychopharmacology

1 November 2017

1 reference

1 November 2017

11

1 reference

1 November 2017

5

1 reference

1 November 2017

327-332

1 reference

Olanzapine-induced glucose dysregulation.

1 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900108-0

7 January 2021

Weight gain associated with psychotropic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900108-0

7 January 2021

Accumulation of dopamine in mouse pancreatic B-cells following injection of L-DOPA. Localization to secretory granules and inhibition of insulin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900108-0

7 January 2021

Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900108-0

7 January 2021

Coated Charcoal Immunoassay of Insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900108-0

7 January 2021

Haloperidol, a dopaminergic antagonist: somatostatin-like inhibition of glucagon and insulin release from the isolated, perfused canine pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900108-0

7 January 2021

Antipsychotic drug-induced obesity in rats: correlation between leptin, insulin and body weight during sulpiride treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900108-0

7 January 2021

Different influences of classical antipsychotics and clozapine on glucose-insulin homeostasis in patients with schizophrenia or related psychoses.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900108-0

7 January 2021

Olanzapine increases weight and serum triglyceride levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900108-0

7 January 2021

Bromocriptine: a novel approach to the treatment of type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900108-0

7 January 2021

Phenothiazines and Diabetes in Hospitalized Women

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900108-0

7 January 2021

Novel antipsychotics and new onset diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900108-0

7 January 2021

The effect of clozapine on glucose metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900108-0

7 January 2021

10.1016/S0924-977X(01)00108-0

Identifiers

DOI

1 reference

1 November 2017

1 reference